Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting
Oral Presentations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
7:45 a.m.
Co-Authors: Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE
Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison
160 A/B/C
7:55 a.m.
Presenter: Matthew Ward, MD
Co-Authors: Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA
Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival
160 A/B/C
8:05 a.m.
Co-Authors: Caudell JJ, Ward MC, Koyfman S, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Trotti A, Siddiqui F, Lee N
Multi-Institution Analysis of Re-Irradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the IMRT Era
160 A/B/C
1:40 p.m.
Presenter: Ehsan Balagamwala, MD
Co-Author: Miller JA, Reddy CA, Angelov L, Suh JH, Tariq MB, Yang K, Djemil T, Magnelli A, Mohammadi AM, Soeder S, Chao ST
Recursive partitioning analysis is predictive of overall survival for patients undergoing spine radiosurgery for spine metastasis
206 A/B
2:20 p.m.
Co-Authors: Miller JA, Balagamwala EH, Berriochoa C, Angelov L, Suh JH, Tariq MB, Yang K, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Benzel EC, Chao ST
Advertisement
The Impact of Instrumentation upon Local Control following Spine Stereotactic Radiosurgery
206 A/B
4:05 p.m.
Co-Authors: Miller JA, Kotecha R, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Ahluwalia MS, Chao ST
The Economic Implication of Upfront Whole-Brain Radiation Therapy for Patients with Limited Brain Metastasis
206 A/B
4:25 p.m.
Presenter: Bindu Manyam, MD
Co-Authors: Manyam BV, Garsa A, Chin RI, Reddy CA, Gastman B, Vidimos AT, Thorstad W, Yom S, Nussenbaum B, Wang S, Koyfman SA
A Multi-Institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated with Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
104 A/B/C
ePoster
3:15 p.m.
Presenter: Ping Xia, PhD
Authors: Xia P, Yu N, Kolar M, Godley A, Chao S, Tendulkar R, Suh J
Quantitative Measures Improve Safety, Quality, Efficiency in Radiotherapy
Room: 052 A
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust